Cargando…
Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes
The use of vincristine (VCR) to treat cancer has been limited by its dose-dependent toxicity and development of drug resistance after repeated administrations. In this study, we investigated the mechanism by which quinine hydrochloride (QN) acts as a sensitizer for VCR. Our experiments used three ki...
Autores principales: | Xu, Yuzhen, Qiu, Liyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494179/ https://www.ncbi.nlm.nih.gov/pubmed/26170660 http://dx.doi.org/10.2147/IJN.S84555 |
Ejemplares similares
-
Correction to “Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy”
por: Wang, Chenyu, et al.
Publicado: (2022) -
Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes
por: Gao, Menghua, et al.
Publicado: (2015) -
Silica nanoparticles coencapsulating gadolinium oxide and horseradish peroxidase for imaging and therapeutic applications
por: Gupta, Nikesh, et al.
Publicado: (2012) -
Marqibo(®) (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
por: Silverman, Jeffrey A., et al.
Publicado: (2012) -
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
por: Webb, M. S., et al.
Publicado: (1995)